Cargando…

Contrast Medium-Induced Encephalopathy After Coronary Angiography– Case Report

INTRODUCTION: Contrast-induced encephalopathy represents a rare, reversible complication that appears after intravenous or intra-arterial exposure to contrast agents. There is no consensus in the literature regarding the mechanism of action. However, the theoretical mechanism is set around the disru...

Descripción completa

Detalles Bibliográficos
Autores principales: Andone, Sebastian, Balasa, Rodica, Barcutean, Laura, Bajko, Zoltan, Ion, Valentin, Motataianu, Anca, Stoian, Adina, Maier, Smaranda
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Sciendo 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8519365/
https://www.ncbi.nlm.nih.gov/pubmed/34722917
http://dx.doi.org/10.2478/jccm-2021-0010
_version_ 1784584432512925696
author Andone, Sebastian
Balasa, Rodica
Barcutean, Laura
Bajko, Zoltan
Ion, Valentin
Motataianu, Anca
Stoian, Adina
Maier, Smaranda
author_facet Andone, Sebastian
Balasa, Rodica
Barcutean, Laura
Bajko, Zoltan
Ion, Valentin
Motataianu, Anca
Stoian, Adina
Maier, Smaranda
author_sort Andone, Sebastian
collection PubMed
description INTRODUCTION: Contrast-induced encephalopathy represents a rare, reversible complication that appears after intravenous or intra-arterial exposure to contrast agents. There is no consensus in the literature regarding the mechanism of action. However, the theoretical mechanism is set around the disruption of the blood-brain barrier and the contrast agents’ chemical properties. CASE REPORT: The case of a 70-year-old patient, known to have hypertension and type 2 diabetes mellitus is reported. The patient had undergone a diagnostic coronary angiography during which he received 100ml of Ioversol (Optiray 350™). Soon after the procedure, the patient began experiencing a throbbing headache, followed by intense behavioural changes and aggressive tendencies. He was transferred to the Neurology Clinic. The neurological examination was without focal neurological signs; however, the patient was very aggressive and uncooperative. The CT scan revealed a mild hyper-density in the frontal lobes. MRI scan revealed no pathological changes. Conservative treatment with diuretics and hydration was administered, and the patient experienced a complete resolution of symptoms in 72 hours. CONCLUSION: Contrast-induced encephalopathy is a possible secondary complication to contrast agents and a diagnostic challenge, and it should not be overlooked, especially following procedures that use contrast agents.
format Online
Article
Text
id pubmed-8519365
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Sciendo
record_format MEDLINE/PubMed
spelling pubmed-85193652021-10-28 Contrast Medium-Induced Encephalopathy After Coronary Angiography– Case Report Andone, Sebastian Balasa, Rodica Barcutean, Laura Bajko, Zoltan Ion, Valentin Motataianu, Anca Stoian, Adina Maier, Smaranda J Crit Care Med (Targu Mures) Case Report INTRODUCTION: Contrast-induced encephalopathy represents a rare, reversible complication that appears after intravenous or intra-arterial exposure to contrast agents. There is no consensus in the literature regarding the mechanism of action. However, the theoretical mechanism is set around the disruption of the blood-brain barrier and the contrast agents’ chemical properties. CASE REPORT: The case of a 70-year-old patient, known to have hypertension and type 2 diabetes mellitus is reported. The patient had undergone a diagnostic coronary angiography during which he received 100ml of Ioversol (Optiray 350™). Soon after the procedure, the patient began experiencing a throbbing headache, followed by intense behavioural changes and aggressive tendencies. He was transferred to the Neurology Clinic. The neurological examination was without focal neurological signs; however, the patient was very aggressive and uncooperative. The CT scan revealed a mild hyper-density in the frontal lobes. MRI scan revealed no pathological changes. Conservative treatment with diuretics and hydration was administered, and the patient experienced a complete resolution of symptoms in 72 hours. CONCLUSION: Contrast-induced encephalopathy is a possible secondary complication to contrast agents and a diagnostic challenge, and it should not be overlooked, especially following procedures that use contrast agents. Sciendo 2021-05-12 /pmc/articles/PMC8519365/ /pubmed/34722917 http://dx.doi.org/10.2478/jccm-2021-0010 Text en © 2021 Sebastian Andone, Rodica Balasa, Laura Barcutean, Zoltan Bajko, Valentin Ion, Anca Motataianu, Adina Stoian, Smaranda Maier, published by Sciendo https://creativecommons.org/licenses/by-nc-nd/4.0/This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
spellingShingle Case Report
Andone, Sebastian
Balasa, Rodica
Barcutean, Laura
Bajko, Zoltan
Ion, Valentin
Motataianu, Anca
Stoian, Adina
Maier, Smaranda
Contrast Medium-Induced Encephalopathy After Coronary Angiography– Case Report
title Contrast Medium-Induced Encephalopathy After Coronary Angiography– Case Report
title_full Contrast Medium-Induced Encephalopathy After Coronary Angiography– Case Report
title_fullStr Contrast Medium-Induced Encephalopathy After Coronary Angiography– Case Report
title_full_unstemmed Contrast Medium-Induced Encephalopathy After Coronary Angiography– Case Report
title_short Contrast Medium-Induced Encephalopathy After Coronary Angiography– Case Report
title_sort contrast medium-induced encephalopathy after coronary angiography– case report
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8519365/
https://www.ncbi.nlm.nih.gov/pubmed/34722917
http://dx.doi.org/10.2478/jccm-2021-0010
work_keys_str_mv AT andonesebastian contrastmediuminducedencephalopathyaftercoronaryangiographycasereport
AT balasarodica contrastmediuminducedencephalopathyaftercoronaryangiographycasereport
AT barcuteanlaura contrastmediuminducedencephalopathyaftercoronaryangiographycasereport
AT bajkozoltan contrastmediuminducedencephalopathyaftercoronaryangiographycasereport
AT ionvalentin contrastmediuminducedencephalopathyaftercoronaryangiographycasereport
AT motataianuanca contrastmediuminducedencephalopathyaftercoronaryangiographycasereport
AT stoianadina contrastmediuminducedencephalopathyaftercoronaryangiographycasereport
AT maiersmaranda contrastmediuminducedencephalopathyaftercoronaryangiographycasereport